Dr. Paul Gratzer is the inventor of the patented decellularization technology (PrECM™) and co-founder of DeCell Technologies Inc. He is a licensed Professional Engineer (P.Eng.) and an Associate Professor in the School of Biomedical Engineering at Dalhousie University in Halifax, NS with cross-appointments in the Departments of Surgery and Process Engineering and Applied Science. Dr. Gratzer holds degrees in Chemical Engineering, Biomaterials Science, and Biomedical Engineering. His research on soft tissue regeneration and decellularization spans over 25+ years. Dr. Gratzer’s research has been highly cited with invitations to write multiple book chapters on decellularization and tissue engineering. Dr. Gratzer’s expertise is sought out by funding agencies, governments, industry groups, scientific societies and journals. His work with DeCell have won the 2015 Discovery Award for Innovation and Best Presenting Company: Early Stage Growth 2014 at the Atlantic Venture Forum.